Skip to content

Progesterone Rise in Agonist Versus Antagonist in Vitro Fertilization (IVF) Cycles

Is the Clinical Outcome Affected by the Incidence of Progesterone Elevation on the Day of hCG Triggering When Agonist Protocol is Compared to Antagonist Protocol for IVF

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01191710
Enrollment
200
Registered
2010-08-31
Start date
2007-01-31
Completion date
2011-01-31
Last updated
2010-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Outcome After In Vitro Fertilization (IVF)

Keywords

progesterone

Brief summary

The aim is to explore whether the incidence of progesterone rise in the late follicular phase differs between GnRH-agonist and GnRH-antagonist protocols for IVF and whether this has an impact on the probability of pregnancy achievement.

Detailed description

In view of the current debate concerning possible differences in efficacy between the two GnRH analogues, the current study aimed to explore whether progesterone control in the late follicular phase differs when GnRH-agonist is used as compared to GnRH-antagonist and if so to what extend does the progesterone rise have an impact on the probability of achieving a pregnancy.

Interventions

OTHERIn vitro fertilization

In vitro fertilization procedure with gonadotropin induced follicular ovarian stimulation

Sponsors

BioGenesis
CollaboratorINDUSTRY
Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* age \< 39 * follicle-stimulating hormone (FSH) \< 12 * gonadotropin dose 100-300IU

Exclusion criteria

* endometriosis * known endocrine disorder * blood analyzed in another laboratory

Design outcomes

Primary

MeasureTime frame
Incidence of late progesterone rise on the day of HCG triggeringUp to delivery (2010)

Secondary

MeasureTime frame
Clinical pregnancy rate Delivery rateUp to delivery (2010)

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026